Status:

RECRUITING

An Investigator-initiated Linked Study to OCEANIC-AF

Lead Sponsor:

East and North Hertfordshire NHS Trust

Collaborating Sponsors:

Liverpool Heart and Chest Hospital NHS Foundation Trust

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18+ years

Brief Summary

Impaired endogenous fibrinolysis is a recently recognised risk factor for thrombotic events in patients with cardiovascular disease. Enhancing endogenous fibrinolysis in such individuals represents a ...

Detailed Description

The risk of a clot forming in a blood vessel, which can cause a heart attack or stroke, is determined partly by how "sticky" the blood is and partly by the effectiveness of the natural defences in the...

Eligibility Criteria

Inclusion

  • Patients aged 18 years or over
  • Patients enrolled in OCEANIC-AF study
  • Free from the exclusion criteria below
  • The patient is willing and able to understand the Patient Information Sheet and provide written informed consent
  • The patient agrees to comply with the drawing of blood samples for the assessments.

Exclusion

  • Inability to provide valid informed consent
  • Patients aged \< 18 years of age
  • Patients with significant neurological, hepatic, renal, endocrine, gastrointestinal, pulmonary, haemorrhagic, metabolic or other disease likely to confound the study requirements or analyses
  • Patients with a history of substance abuse or signs or clinical features of active substance abuse or psychiatric disease
  • Alcohol consumption above 21 units per week
  • Any illness deemed significant by the investigator during the four (4) weeks preceding the screening period of the study
  • Any major bleeding diathesis or blood dyscrasia (platelets \<70 x 109/l, Hb \<80 g/dl, INR \>1.4, APTT \>x 2 UNL, leucocyte count \<3.5 x 109/l, neutrophil count \<1 x 109/l)

Key Trial Info

Start Date :

November 3 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 17 2026

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06124612

Start Date

November 3 2023

End Date

September 17 2026

Last Update

November 9 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Liverpool Heart and Chest Hospital

Liverpool, United Kingdom

2

East and North Herts NHS Trust

Stevenage, United Kingdom